Effect of Probiotic on Oral Health of Children
Effect of Probiotic Lactobacillus Salivarius and Cranberry on Oral Health of Children
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Warsaw, 18 Miodowa Saint
-
Warsaw, Warsaw, 18 Miodowa Saint, Poland, 00-246
- Recruiting
- Dorota Olczak-Kowalczyk
-
Contact:
- Dorota Olczak-Kowalczyk, Ass.Prof.
- Phone Number: +48 22 502 20 31
- Email: pedodoncja@wum.edu.pl
-
Principal Investigator:
- Anna Turska-Szybka, Phd, MD
-
Principal Investigator:
- Dorota Olczak-Kowalczyk, Ass.Prof.
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- generally healthy children aged 3-6;
- recognized caries of early childhood, dmf> 1,
- lack of active caries and inflammation of the mouth
- colony forming unit CFU > 105 / ml Streptococcus mutans
- a minimum of one-month period from: the last antibiotic therapy, probiotic use, professional fluoride prophylaxis or supervised tooth brushing with fluoride preparations, the use of fluoride toothpaste, not using xylitol, written consent of parents / legal guardians for participation in research.
Exclusion Criteria:
- chronic diseases and chronically taken medicines in the past,
- planned change of residence during the year,
- age below 3 and above 6 years,
- healthy teeth, dmf = 0,
- colony forming unit CFU <105 / ml Streptococcus mutans
- Patient during antibiotic therapy, probiotic use, professional fluoride prophylaxis or supervised tooth brushing with fluoride preparations
- no toothpaste with fluoride
- using xylitol
- lack of written consent of parents / legal guardians for participation in research.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Active Comparator: Probiotics
Participants will receive two lozenges containing probiotic bacteria and cranberry.
|
A half of the participants will be randomly allocated to the probiotics group.
They will receive two probiotics lozenge before falling asleep for 8 weeks.
Clinical examination will be conducted before study and after 8 weeks.
|
|
Placebo Comparator: Placebo - No probiotics
Participants will receive a control two lozenges containing no probiotic bacteria.
|
A half of the participants will be randomly allocated to the placebo group.
They will receive two no probiotics lozenge before falling asleep for 8 weeks.
Clinical examination will be conducted before study and after 8 weeks.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changing the titre of the carcinogenic bacteria Streptococcus mutans
Time Frame: 8 weeks
|
During control tests saliva will be applied to the medium for identification and detailed quantification of S. mutans bacteria.
After the incubation, the number of bacteria will be expressed - taking into account the degree of saliva dilution - as the number of colony-forming unit (CFU) in 1 ml of saliva.
|
8 weeks
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Anticipated)
Primary Completion
Study Completion (Anticipated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- KB/232/2016
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.